These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34697402)

  • 1. Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective.
    Pokrzywinski R; Hareendran A; Nalysnyk L; Cowie S; Crowe J; Hopkin J; Joshi D; Pulikottil-Jacob R
    Sci Rep; 2021 Oct; 11(1):20972. PubMed ID: 34697402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD).
    McGovern MM; Avetisyan R; Sanson BJ; Lidove O
    Orphanet J Rare Dis; 2017 Feb; 12(1):41. PubMed ID: 28228103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.
    Raebel EM; Wiseman S; Donnelly C; Mathieson T; Pountney J; Crowe J; Hopkin J
    Orphanet J Rare Dis; 2024 Feb; 19(1):36. PubMed ID: 38303068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health insurance literacy and health services access barriers in Niemann-Pick disease: the patient and caregiver voice.
    Diaz GA; Crowe J; Hopkin J
    Orphanet J Rare Dis; 2022 Sep; 17(1):332. PubMed ID: 36056366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
    Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
    Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis.
    Pulikottil-Jacob R; Ganz ML; Fournier M; Petruski-Ivleva N
    Adv Ther; 2023 May; 40(5):2234-2248. PubMed ID: 36897522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Potential Symptoms and Risks Associated with Acid Sphingomyelinase Deficiency on Patients and Caregivers: A Best-Worst Scaling Study.
    Mansfield C; Nalysnyk L; Joshi D; Coulter J; Pulikottil-Jacob R
    Patient Prefer Adherence; 2023; 17():927-939. PubMed ID: 37020662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation.
    McGovern MM; Wasserstein MP; Bembi B; Giugliani R; Mengel KE; Vanier MT; Zhang Q; Peterschmitt MJ
    Orphanet J Rare Dis; 2021 May; 16(1):212. PubMed ID: 33971920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany.
    Mengel E; Muschol N; Weinhold N; Ziagaki A; Neugebauer J; Antoni B; Langer L; Gasparic M; Guillonneau S; Fournier M; Laredo F; Pulikottil-Jacob R
    Orphanet J Rare Dis; 2024 Apr; 19(1):161. PubMed ID: 38615062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic odyssey for patients with acid sphingomyelinase deficiency (ASMD): Exploring the potential indicators of diagnosis using quantitative and qualitative data.
    Doerr A; Farooq M; Faulkner C; Gould R; Perry K; Pulikottil-Jacob R; Rajasekhar P
    Mol Genet Metab Rep; 2024 Mar; 38():101052. PubMed ID: 38469089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase deficiency in France: a retrospective survival study.
    Mauhin W; Guffon N; Vanier MT; Froissart R; Cano A; Douillard C; Lavigne C; Héron B; Belmatoug N; Uzunhan Y; Lacombe D; Levade T; Duvivier A; Pulikottil-Jacob R; Laredo F; Pichard S; Lidove O;
    Orphanet J Rare Dis; 2024 Aug; 19(1):289. PubMed ID: 39103853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus.
    Scarpa M; Barbato A; Bisconti A; Burlina A; Concolino D; Deodato F; Di Rocco M; Dionisi-Vici C; Donati MA; Fecarotta S; Fiumara A; Galeone C; Giona F; Giuffrida G; Manna R; Mariani P; Pession A; Scopinaro A; Spada M; Spandonaro F; Trifirò G; Carubbi F; Cappellini MD
    Intern Emerg Med; 2023 Apr; 18(3):831-842. PubMed ID: 36882619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD).
    Matza LS; Stewart KD; Fournier M; Rowen D; Lachmann R; Scarpa M; Mengel E; Obermeyer T; Ayik E; Laredo F; Pulikottil-Jacob R
    Eur J Health Econ; 2024 Nov; 25(8):1437-1448. PubMed ID: 38409492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy.
    Jones SA; McGovern M; Lidove O; Giugliani R; Mistry PK; Dionisi-Vici C; Munoz-Rojas MV; Nalysnyk L; Schecter AD; Wasserstein M
    Mol Genet Metab; 2020; 131(1-2):116-123. PubMed ID: 32616389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann-Pick disease types A, B and A/B).
    Geberhiwot T; Wasserstein M; Wanninayake S; Bolton SC; Dardis A; Lehman A; Lidove O; Dawson C; Giugliani R; Imrie J; Hopkin J; Green J; de Vicente Corbeira D; Madathil S; Mengel E; Ezgü F; Pettazzoni M; Sjouke B; Hollak C; Vanier MT; McGovern M; Schuchman E
    Orphanet J Rare Dis; 2023 Apr; 18(1):85. PubMed ID: 37069638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic visceral acid sphingomyelinase deficiency (Niemann-Pick disease type B) in 16 Polish patients: long-term follow-up.
    Lipiński P; Kuchar L; Zakharova EY; Baydakova GV; Ługowska A; Tylki-Szymańska A
    Orphanet J Rare Dis; 2019 Feb; 14(1):55. PubMed ID: 30795770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with chronic acid sphingomyelinase deficiency (ASMD) in the United States: A retrospective chart review study.
    Pulikottil-Jacob R; Dehipawala S; Smith B; Athavale A; Gusto G; Chandak A; Khachatryan A; Banon T; Fournier M; Guillonneau S; Pollissard L; Munoz-Rojas MV
    Mol Genet Metab Rep; 2024 Mar; 38():101040. PubMed ID: 38188692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts and Burden of Niemann pick Type-C: a patient and caregiver perspective.
    Mengel E; Patterson MC; Chladek M; Guldberg C; Í Dali C; Symonds T; Lloyd-Price L; Mathieson T; Crowe J; Burbridge C
    Orphanet J Rare Dis; 2021 Nov; 16(1):493. PubMed ID: 34819124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD).
    Wasserstein M; Dionisi-Vici C; Giugliani R; Hwu WL; Lidove O; Lukacs Z; Mengel E; Mistry PK; Schuchman EH; McGovern M
    Mol Genet Metab; 2019 Feb; 126(2):98-105. PubMed ID: 30514648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.
    Eskes ECB; van der Lienden MJC; Sjouke B; van Vliet L; Brands MMMG; Hollak CEM; Aerts JMFG
    Mol Genet Metab; 2023 Aug; 139(4):107631. PubMed ID: 37453187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.